Back to browse

EXP001454

Paper

Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery (2017)

Peptide

SRCRP2-11-R (DMBT1-derived CPP mutant)

Sequence: GRVRVLYRGSW

RNA

siRNA

All experiment fields

Experiment Id EXP001454
Paper Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
Peptide SRCRP2-11-R (DMBT1-derived CPP mutant)
Delivery Success Class no
In Vivo Flag no
Uptake Confirmed yes
Label Confidence high
In Vitro Functional Effect yes
Endosomal Escape Evidence
Peptide Concentration Final peptide 15.0 µM (with 100 nM siRNA) for knockdown assay; molar ratio 150:1 (peptide:siRNA).
Rna Concentration Final siRNA 100 nM in cell culture (reverse transfection, 96 h).
Mixing Ratio Peptide/siRNA molar ratio 150:1 (peptide:siRNA). Complexes formed in PBS (30 min, 37°C) before use.
Formulation Format Self-assembled peptide/siRNA nanocomplexes (noncovalent electrostatic complexes)
Formulation Components SRCRP2-11-R (DMBT1-derived CPP mutant) peptide + tdTomato1 siRNA (or non-targeting control); complexes delivered in (reported) FBS-free conditions for knockdown readout.
Size Nm
Zeta Mv
Model Scope in_vitro
Model Type in vitro
Cell Lines Or Primary Cells MCF7 tdTomato stable recombinant cells (knockdown); MCF7 cells for uptake (FITC-peptide + Cy3-siRNA confocal, 24 h).
Animal Model
Administration Route
Output Type In vitro functional effect: tdTomato fluorescence knockdown at 96 h (normalized to viability) + uptake confirmed by confocal microscopy and fluorescence measurements (24 h) for peptide/Cy3-siRNA complexes.
Output Value ~55% tdTomato knockdown at optimal ratio.
Output Units
Output Notes Optimal knockdown at 150:1. Reported ~55% tdTomato knockdown vs untreated at 96 h; non-targeting siRNA complexes did not significantly change fluorescence.
Toxicity Notes No clear morphological toxicity reported in confocal images; viability normalization performed for knockdown readout.
Curation Notes